Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06570746
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
Comparison of the Effectiveness of Conventional Radiofrequency Thermocoagulation and Chemical Ablation With Phenol on Articular Branches of Femoral and Obturator Nerves in Chronic Hip Pain
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of the Effectiveness of Conventional Radiofrequency Thermocoagulation and Chemical Ablation With Phenol on Articular Branches of Femoral and Obturator Nerves in Chronic Hip Pain
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In our study we aimed to compare the effects of conventional radiofrequency thermocoagulation applied to the articular branches of the femoral and obturator nerves with chemical ablation using phenol on hip pain
Detailed Description:
Our study is designed as a double-blind prospective randomized controlled trial Blinding will be ensured by keeping the researcher performing pain diary follow-ups unaware of which procedure was applied to each patient
Patients will be randomized using computer-assisted methods Following approval from the hospital ethics committee clinical trial registration will be conducted From 2024 to 2025 patients presenting with chronic hip pain to the Department of Algology at ADU Faculty of Medicine will be divided into two groups In Group 1 chemical ablation of the femoral and obturator nerve branches with phenol under ultrasound guidance will be performed In Group 2 conventional radiofrequency thermocoagulation of the articular branches of the femoral and obturator nerves under ultrasound guidance will be applied
During the study pain intensity will be assessed using the Numerical Rating Scale NRS at baseline 2 hours post-procedure and at 1 month and 3 months post-procedure for both Group 1 and Group 2 The WOMAC scale will be used to evaluate their functional capacity
Patients will be randomized using computer-assisted methods Following approval from the hospital ethics committee clinical trial registration will be conducted From 2024 to 2025 patients presenting with chronic hip pain to the Department of Algology at ADU Faculty of Medicine will be divided into two groups In Group 1 chemical ablation of the femoral and obturator nerve branches with phenol under ultrasound guidance will be performed In Group 2 conventional radiofrequency thermocoagulation of the articular branches of the femoral and obturator nerves under ultrasound guidance will be applied
During the study pain intensity will be assessed using the Numerical Rating Scale NRS at baseline 2 hours post-procedure and at 1 month and 3 months post-procedure for both Group 1 and Group 2 The WOMAC scale will be used to evaluate their functional capacity
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None